Compare AAT & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAT | OMCL |
|---|---|---|
| Founded | 1967 | 1992 |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | Computer Manufacturing |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2010 | 2000 |
| Metric | AAT | OMCL |
|---|---|---|
| Price | $21.73 | $37.47 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $23.50 | ★ $57.43 |
| AVG Volume (30 Days) | 384.9K | ★ 581.0K |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | ★ 6.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.30 | ★ 1.01 |
| Revenue | $436,204,000.00 | ★ $787,309,000.00 |
| Revenue This Year | $2.49 | $3.69 |
| Revenue Next Year | $3.76 | $0.92 |
| P/E Ratio | $72.12 | ★ $36.97 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $17.72 | $31.75 |
| 52 Week High | $25.97 | $51.84 |
| Indicator | AAT | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 55.16 |
| Support Level | $20.56 | $35.57 |
| Resistance Level | $21.76 | $44.35 |
| Average True Range (ATR) | 0.60 | 1.79 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 64.73 | 46.33 |
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.